🚨 Join Ash Alavijeh at BioWednesday! 🚨
January 8, 2025
Pharmidex’s
Head of Operations,
Ash Alavijeh, will attend the BioWednesday Social:
One Nucleus Annual Awards Launch Event!
📅 Date: 8 January 2025
⏰ Time: 18:00 - 21:00
📍 Venue: The Euston Flyer, London, NW1 2RA
🔗 https://lnkd.in/eYZC9DYv
Ash looks forward to connecting with attendees, fostering collaborations, and exploring opportunities to advance preclinical research and healthcare innovation.
Let’s shape the future of science together!
#Pharmidex #OneNucleus #Innovation #Collaboration
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩🔬 👨🔬 Welcome to the team, Gabrielle and Mohammed!
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
